These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1178 related items for PubMed ID: 26276090

  • 1. Bone marrow niche in the myelodysplastic syndromes.
    Cogle CR, Saki N, Khodadi E, Li J, Shahjahani M, Azizidoost S.
    Leuk Res; 2015 Oct; 39(10):1020-7. PubMed ID: 26276090
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Coexistence of aberrant hematopoietic and stromal elements in myelodysplastic syndromes.
    Abbas S, Kini A, Srivastava VM, M MT, Nair SC, Abraham A, Mathews V, George B, Kumar S, Venkatraman A, Srivastava A.
    Blood Cells Mol Dis; 2017 Jul; 66():37-46. PubMed ID: 28822917
    [Abstract] [Full Text] [Related]

  • 5. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
    Das M, Chatterjee S, Basak P, Das P, Pereira JA, Dutta RK, Chaklader M, Chaudhuri S, Law S.
    J Stem Cells; 2010 Jul; 5(2):49-64. PubMed ID: 22049615
    [Abstract] [Full Text] [Related]

  • 6. Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH.
    Oliveira FM, Lucena-Araujo AR, Favarin Mdo C, Palma PV, Rego EM, Falcão RP, Covas DT, Fontes AM.
    Exp Hematol; 2013 Feb; 41(2):198-208. PubMed ID: 23092930
    [Abstract] [Full Text] [Related]

  • 7. Biology of the bone marrow microenvironment and myelodysplastic syndromes.
    Rankin EB, Narla A, Park JK, Lin S, Sakamoto KM.
    Mol Genet Metab; 2015 Feb; 116(1-2):24-8. PubMed ID: 26210353
    [Abstract] [Full Text] [Related]

  • 8. Biologic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes.
    Kastrinaki MC, Pontikoglou C, Klaus M, Stavroulaki E, Pavlaki K, Papadaki HA.
    Curr Stem Cell Res Ther; 2011 Jun; 6(2):122-30. PubMed ID: 20528751
    [Abstract] [Full Text] [Related]

  • 9. Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit.
    Medyouf H, Mossner M, Jann JC, Nolte F, Raffel S, Herrmann C, Lier A, Eisen C, Nowak V, Zens B, Müdder K, Klein C, Obländer J, Fey S, Vogler J, Fabarius A, Riedl E, Roehl H, Kohlmann A, Staller M, Haferlach C, Müller N, John T, Platzbecker U, Metzgeroth G, Hofmann WK, Trumpp A, Nowak D.
    Cell Stem Cell; 2014 Jun 05; 14(6):824-37. PubMed ID: 24704494
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bone marrow niches in myeloid neoplasms.
    Kitagawa M, Kurata M, Onishi I, Yamamoto K.
    Pathol Int; 2020 Feb 05; 70(2):63-71. PubMed ID: 31709722
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes.
    Varga G, Kiss J, Várkonyi J, Vas V, Farkas P, Pálóczi K, Uher F.
    Pathol Oncol Res; 2007 Feb 05; 13(4):311-9. PubMed ID: 18158566
    [Abstract] [Full Text] [Related]

  • 16. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
    Tauro S, Hepburn MD, Bowen DT, Pippard MJ.
    Haematologica; 2001 Oct 05; 86(10):1038-45. PubMed ID: 11602409
    [Abstract] [Full Text] [Related]

  • 17. In vitro study of biological characteristics of mesenchymal stem cells in patients with low-risk myelodysplastic syndrome.
    Zhang YZ, Zhao DD, Han XP, Jin HJ, Da WM, Yu L.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug 05; 16(4):813-8. PubMed ID: 18718067
    [Abstract] [Full Text] [Related]

  • 18. Cytogenetic evaluation of mesenchymal stem/stromal cells from patients with myelodysplastic syndromes at different time-points during ex vivo expansion.
    Kouvidi E, Stratigi A, Batsali A, Mavroudi I, Mastrodemou S, Ximeri M, Papadaki HA, Pontikoglou CG.
    Leuk Res; 2016 Apr 05; 43():24-32. PubMed ID: 26930455
    [Abstract] [Full Text] [Related]

  • 19. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Blau O, Hofmann WK, Baldus CD, Thiel G, Serbent V, Schümann E, Thiel E, Blau IW.
    Exp Hematol; 2007 Feb 05; 35(2):221-9. PubMed ID: 17258071
    [Abstract] [Full Text] [Related]

  • 20. Bone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expression.
    Weickert MT, Hecker JS, Buck MC, Schreck C, Rivière J, Schiemann M, Schallmoser K, Bassermann F, Strunk D, Oostendorp RAJ, Götze KS.
    Sci Rep; 2021 Mar 15; 11(1):5944. PubMed ID: 33723276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.